This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2001 Mar;7(3):285-7.

doi: 10.1038/85417.

CYP3A genetics in drug metabolism

M Eichelbaum, O Burk

PMID: 11231620
DOI: 10.1038/85417

CYP3A genetics in drug metabolism

M Eichelbaum et al. Nat Med. 2001 Mar.

. 2001 Mar;7(3):285-7.

doi: 10.1038/85417.

Authors

M Eichelbaum, O Burk

PMID: 11231620
DOI: 10.1038/85417

No abstract available

PubMed Disclaimer

Similar articles

[Molecular mechanism of the expression and modulation of CYP3A gene].
Wang JS, Zhou HH. Wang JS, et al. Sheng Li Ke Xue Jin Zhan. 1998 Apr;29(2):173-6. Sheng Li Ke Xue Jin Zhan. 1998. PMID: 12501692 Review. Chinese. No abstract available.
Genetics. SNP-ing drugs to size.
Gura T. Gura T. Science. 2001 Jul 27;293(5530):595. doi: 10.1126/science.293.5530.595. Science. 2001. PMID: 11474082 No abstract available.
Effects of disease on expression and regulation of CYPs.
Farrell G. Farrell G. Mol Aspects Med. 1999 Feb-Apr;20(1-2):55-70, 137. Mol Aspects Med. 1999. PMID: 10575652 Review. No abstract available.
Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
Martínez C, García-Martín E, Pizarro RM, García-Gamito FJ, Agúndez JA. Martínez C, et al. Br J Cancer. 2002 Sep 9;87(6):681-6. doi: 10.1038/sj.bjc.6600494. Br J Cancer. 2002. PMID: 12237780 Free PMC article.
Cyp3A regulation: from pharmacology to nuclear receptors.
Quattrochi LC, Guzelian PS. Quattrochi LC, et al. Drug Metab Dispos. 2001 May;29(5):615-22. Drug Metab Dispos. 2001. PMID: 11302925 Review.

See all similar articles

Cited by

Genetic association of a polymorphism of the cAMP-responsive element binding protein-binding protein with steroid-induced osteonecrosis after kidney transplantation.
Tamura K, Nakajima S, Hirota Y, Takahashi KA, Fujioka M, Kubo T, Iwatani Y, Ozono K. Tamura K, et al. J Bone Miner Metab. 2007;25(5):320-5. doi: 10.1007/s00774-007-0770-z. Epub 2007 Aug 25. J Bone Miner Metab. 2007. PMID: 17704997
Cunninghamella as a microbiological model for metabolism of histamine H(3) receptor antagonist 1-[3-(4-tert-butylphenoxy)propyl]piperidine.
Pękala E, Kubowicz P, Łażewska D. Pękala E, et al. Appl Biochem Biotechnol. 2012 Nov;168(6):1584-93. doi: 10.1007/s12010-012-9880-8. Epub 2012 Sep 16. Appl Biochem Biotechnol. 2012. PMID: 22983742 Free PMC article.
Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Lytton SD, Berg U, Nemeth A, Ingelman-Sundberg M. Lytton SD, et al. Clin Exp Immunol. 2002 Feb;127(2):293-302. doi: 10.1046/j.1365-2249.2002.01754.x. Clin Exp Immunol. 2002. PMID: 11876753 Free PMC article.
4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans.
Diczfalusy U, Nylén H, Elander P, Bertilsson L. Diczfalusy U, et al. Br J Clin Pharmacol. 2011 Feb;71(2):183-9. doi: 10.1111/j.1365-2125.2010.03773.x. Br J Clin Pharmacol. 2011. PMID: 21219398 Free PMC article. Review.
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance).
Lewis LD, Miller AA, Owzar K, Bies RR, Markova S, Jiang C, Kroetz DL, Egorin MJ, McLeod HL, Ratain MJ; Alliance for Clinical Trials in Oncology. Lewis LD, et al. Pharmacogenet Genomics. 2013 Jan;23(1):29-33. doi: 10.1097/FPC.0b013e32835b16d8. Pharmacogenet Genomics. 2013. PMID: 23188068 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group